Summary

The South & Central America brain implants market was valued at US$ 366.05 million in 2022 and is expected to reach US$ 730.98 million by 2030; it is estimated to grow at a CAGR of 9.0% from 2022 to 2030.

Strategic Initiatives by Companies Fuels South & Central America Brain Implants Market

Companies operating in the brain implants market constantly focus on strategic developments such as product approvals, collaborations, expansions, agreements, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. For example, in December 2022, Abbott launched the Eterna spinal cord stimulation (SCS) system, which is the smallest implantable, rechargeable SCS system available on the market for the treatment of chronic pain. The company's portfolio of neuromodulation devices also includes Proclaim XR, the recharge-free SCS system, and Proclaim Plus featuring FlexBurst360.

Brain implant manufacturers are taking steps to expand their operations around the world and launch their products in different regions, which is expected to boost the market penetration and accessibility of their offerings. Therefore, product introduction and strategic moves such as approvals, expansions, and acquisitions create significant growth opportunities in the South & Central America brain implants market.

South & Central America Brain Implants Market Overview

The South & Central America brain implants market is segmented into Brazil, Argentina, and the Rest of South & Central America. South & Central America will likely account for over 9.0% of the brain implant market during 2022-2030. The prevalence of neurological disorders, such as Parkinson's disease and Alzheimer's disease, has been linked to the aging population in Brazil. According to the data from the Pan American Health Organization (PAHO), Brazil has over 30 million people aged 60 years and above, representing 13% of the country's population. By 2030, this age group is expected to reach ~50 million, representing 24% of the Brazilian population. As per the Brazilian Institute of Country and Statistics, the country's population aged 65 and above is expected to hold a 36% share of the total population of Brazil by 2050. As per the study, "Trends in mortality from Alzheimer's disease in Brazil, 2000-2019," published in 2023, in Brazil, Alzheimer's disease has become a major health concern since the population is increasingly aging, coupled with the increasing mortality rates and the growing prevalence of the disease in the country in recent years. There was a 49% increase in deaths due to Alzheimer's disease between 2009 and 2019 in the country, making it the seventh leading cause of death. More than 211,600 deaths were due to Alzheimer's disease in the same period in Brazil, 64% of which were female. Furthermore, 73% of the deaths were related to people aged 80 and above, and 27% were in the 60-79 age group. Thus, the abovementioned factors are expected to increase the demand for brain implants for the treatment of these neurological diseases in the country in the coming years.

South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Brain Implants Market Segmentation

The South & Central America brain implants market is segmented into treatment, application, end user, and country.

Based on treatment, the South & Central America brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. The spinal cord stimulation segment held the largest share in 2022. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment. The spinal cord stimulation segment held the largest share in 2022.

In terms of application, the South & Central America brain implants market is categorized into chronic pain, Parkinson's disease, Alzheimer's disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held the largest share in 2022.

Based on end user, the South & Central America brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held the largest share in 2022.

Based on country, the South & Central America brain implants market is segmented Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America brain implants market in 2022.

Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, and Renishaw Plc are some of the leading companies operating in the South & Central America brain implants market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Brain Implants Market Landscape
4.1 Overview
5. South & Central America Brain Implants Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
5.1.2 Rising Number of Spinal Cord Injuries
5.2 Key Market Restraints
5.2.1 High Cost Associated with Brain Implant Devices and Procedures
5.3 Key Market Opportunities
5.3.1 Strategic Initiatives by Companies
5.4 Key Future Trends
5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain-Machine Interfaces
5.5 Impact Analysis:
6. Brain Implants Market - South & Central America Market Analysis
6.1 Overview
6.2 South & Central America Brain Implants Market Revenue (US$ Mn), 2022 - 2030
7. South & Central America Brain Implants Market - Revenue and Forecast to 2030 - by Treatment.
7.1 Overview
7.2 South & Central America Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Deep Brain Stimulation
7.3.1 Overview
7.3.2 Deep Brain Stimulation: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Spinal Cord Stimulation
7.4.1 Overview
7.4.2 Spinal Cord Stimulation: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Vagus Nerve Stimulator
7.5.1 Overview
7.5.2 Vagus Nerve Stimulator: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Invasive and Non-Invasive Brain-Computer Interfaces
7.6.1 Overview
7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Responsive Neurostimulation for Seizures
7.7.1 Overview
7.7.2 Responsive Neurostimulation for Seizures: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Auditory Brainstem Implant
7.8.1 Overview
7.8.2 Auditory Brainstem Implant: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
7.8.2.1 Retrocochlear Hearing Impairment
7.8.2.1.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.8.2.2 Cochlear Hearing Impairment
7.8.2.2.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.9 Ophthalmic Aids/Implant
7.9.1 Overview
7.9.2 Ophthalmic Aids/Implant: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Brain Implants Market - Revenue and Forecast to 2030 - by Application
8.1 Overview
8.2 South & Central America Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Chronic Pain
8.3.1 Overview
8.3.2 Chronic Pain: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Parkinson's disease
8.4.1 Overview
8.4.2 Parkinson's disease: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer's disease
8.5.1 Overview
8.5.2 Alzheimer's disease: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Epilepsy
8.6.1 Overview
8.6.2 Epilepsy: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Essential Tremor
8.7.1 Overview
8.7.2 Essential Tremor: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Depression
8.8.1 Overview
8.8.2 Depression: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Dystonia
8.9.1 Overview
8.9.2 Dystonia: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.10 Amyotrophic Lateral Sclerosis
8.10.1 Overview
8.10.2 Amyotrophic Lateral Sclerosis (ALS): South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
8.11 Neurofibromatosis 2
8.11.1 Overview
8.11.2 Neurofibromatosis 2: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Brain Implants Market - Revenue and Forecast to 2030 - by End-User
9.1 Overview
9.2 South & Central America Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Specialized Clinics / Neurological Centers
9.4.1 Overview
9.4.2 Specialized Clinics / Neurological Centers: South & Central America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Brain Implants Market - Country Analysis
10.1 South & Central America Brain Implants Market, by Key Country-Revenue, 2022(US $ Million)
10.1.1 South & Central America Brain Implants Market, by Country
10.1.1.1 Brazil
10.1.1.1.1 Brazil: South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 Brazil: South & Central America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.1.2.1 Brazil: South & Central America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.1.3 Brazil: South & Central America Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 Brazil: South & Central America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.2 Argentina
10.1.1.2.1 Argentina: South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Argentina: South & Central America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.2.2.1 Argentina: South & Central America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.2.3 Argentina: South & Central America Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.4 Argentina: South & Central America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.3 Rest of South & Central America
10.1.1.3.1 Rest of South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 Rest of South & Central America: South & Central America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.3.2.1 Rest of South & Central America: South & Central America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.3.3 Rest of South & Central America: South & Central America Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.4 Rest of South & Central America: South & Central America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
11. South & Central America Brain Implants Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in South & Central America Brain Implants Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Boston Scientific Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Renishaw Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Abbott Laboratories
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms